Correlation Between Inhibrx and Univar
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Univar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Univar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Univar Inc, you can compare the effects of market volatilities on Inhibrx and Univar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Univar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Univar.
Diversification Opportunities for Inhibrx and Univar
Very good diversification
The 3 months correlation between Inhibrx and Univar is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Univar Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Univar Inc and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Univar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Univar Inc has no effect on the direction of Inhibrx i.e., Inhibrx and Univar go up and down completely randomly.
Pair Corralation between Inhibrx and Univar
If you would invest 3,593 in Univar Inc on September 29, 2024 and sell it today you would earn a total of 0.00 from holding Univar Inc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Inhibrx vs. Univar Inc
Performance |
Timeline |
Inhibrx |
Univar Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibrx and Univar Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Univar
The main advantage of trading using opposite Inhibrx and Univar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Univar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Univar will offset losses from the drop in Univar's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Univar vs. Valhi Inc | Univar vs. Huntsman | Univar vs. Lsb Industries | Univar vs. Westlake Chemical Partners |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |